Finally, even though we did not find any functional effect of the VEGFArs25648 SNP to modulate immune responses, our genetic findings are in line with previous studies reporting an increased vascularity and VEGFA levels in AML patients, and a specific VEGFA-dependent vascular morphology in the leukemic BM40. The gene discussed is VEGFA; the disease is acute myeloid leukemia.